Clear Labs key facts
as of Oct 2026- Developer of a comprehensive whole-genome sequencing platform intended to enhance pathogen surveillance and infectious disease outbreak management.
- Clear Labs is valued at approximately $413.0M as of Oct 2026, set at its later-stage round, Dec 2024; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $173.3M across 4 recorded rounds; the latest was Early Stage VC ($29.1M) in Dec 2024.
- Notable investors include Plug and Play Tech Center, Alumni Ventures, Khosla Ventures, GV, Menlo Ventures — 31 tracked in total.
- Clear Labs has filed 5 Form Ds with the SEC since 2015, most recently Dec 2024 ($29.1M sold to 33 investors).
- Status: Privately Held (backing).
Valued at $413.0M at its later-stage round, Dec 2024. Nothing has traded since.
- ·The complete investor list: 31 names
- ·Watch Clear Labs: the Monday email on marks, rounds and moves
Clear Labs funding rounds
4 roundsWho backs Clear Labs
31+Membership and data by Private Market View
Clear Labs valuation
Clear Labs was valued at $413 million at its later-stage round in Dec 2024. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Clear Labs raised?
Clear Labs has raised $173 million across 4 recorded rounds since 2015. The largest was a $6.2 million early-stage round in Aug 2015; the most recent was a $29.1 million early-stage round in Dec 2024.
Clear Labs has filed 5 Form Ds with the SEC since 2015, most recently in Dec 2024 ($29.1 million sold to 33 investors).
Clear Labs investors
31 investors are on record for Clear Labs, including Plug and Play Tech Center, Alumni Ventures, Khosla Ventures and GV. By type, the record holds 14 venture capital firms and 1 family office. The early-stage round in Dec 2024 drew 33 investors.
About Clear Labs
Developer of a comprehensive whole-genome sequencing platform intended to enhance pathogen surveillance and infectious disease outbreak management. The company's platform integrates automated sequencing with advanced bioinformatics, facilitating rapid detection and analysis of pathogens, enabling public health agencies and food safety organizations to improve response times and ensure consumer safety through precise genomic insights.
- Sector
- Healthcare
- HQ
- San Carlos, CA, United States
- Founded
- 2014
- Employees
- 83
- Website
- clearlabs.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.